N116 Unit 1 Lesson 3

33 flashcardsby kylam
Study these flashcardsFree · spaced repetition · iPhone, Android, Mac & web

All cards

1
pharmacology
study of medications
2
drug
substance capable of producing a biologic response
3
medication
drug given for the purpose of producing a therapeutic resposne
4
effective use of drugs & medication depends on being able to apply knowledge related to (5)
-A&P
-pathophysiology
-chemistry
-microbiology
-nursing process
5
therapeutics
branch of medicine concerned with prevention of disease and treatment of suffering
6
pharmacotherapuetics
refers using medications to prevent disease and treat suffering
7
traditional medications
produced by a pharmaceutical manufacturer
8
biologics (2)
agents produced by animal cells and microorganisms
-e.g. hormones, antibodies, vaccines
9
natural health products (3)
-Natural plant extracts
-Vitamins, minerals
-Dietary supplements
10
prescription drugs (2)
Require a dispensing order (prescription) from a qualified health care professional prior to patient receiving drug
-traditional medicines, biologics
11
benefits of prescription drugs (3)
-Health care provider can examine patient prior to ordering medication, ensuring that order is appropriate for patient and condition
-Dose and frequency of dispensed drug can be controlled
-Patient provided with education about drug including dosing, interactions, adverse effects
12
over the counter drugs (OTC) (2)
Drugs that can be obtained by patients without consultation with a health care provider
-Traditional medications, natural health products
13
benefits of OTC drugs (3)
-Usually have a high margin of safety and few adverse effects
-Patients can treat themselves for common conditions by following directions on packaging
-convenience
14
nomenclature of drugs
chemical, generic, trade names e.g.
Chemical: N-Acetly-para-acetylaminophenol
Generic: Acetamniophen
trade: Tylenol
15
supplements (4)
-Herbal and dietary supplements are not drugs.
-Not subjected to same regulatory process
-Can cause side effects and interact with prescription and OTC drugs
-Monitoring through Health Canada food branch
16
schedule 1 (2)
-requires prescription and pharmacist dispensation
-All prescription drugs, Schedule F and G, narcotics
17
schedule 2
requires pharmacist dispensation
18
schedule 3
available at pharmacy or pharmacy area (OTC)
19
schedule 4
can be sold at any store, no professional supervision
20
controlled drug and substances act (CDSA) schedules (2)
-triplicate prescription, provincial monitoring
-narcotics, amphetamines, barbiturates, etc.
21
canadian drug regulations
created to protect the public from drug misuse and provide mechanism for quality assurance for safety and efficacy
22
Health products and food branch (HPFB) of health canada (2)
responsible for ensuring the safety and quality of drugs, biologics, and natural health products
-standard is set by Food and Drug Act and Regulations
23
therapeutic products directorate (TPD) (3)
-Federal authority that regulates pharmaceutical drugs
-Manufacturer must provide substantive evidence of a drug's safety, efficacy and quality, per Food and Drugs Act and Regulations, to TPD for approval
-TPD approval required for drug to be marketed in Canada
24
biologics and genetic therapies directorate
Parallel branch to TPD that regulates biologics and radiopharmaceuticals
25
Natural and Non-Prescription Health Products Directorate (2)
-parallel branch to TPD that regulates natural health products
-Not all countries have such regulations OR have different regulations ie food vs drug
26
canadian drug approval process - step 1
preclinical trials using cultured cells, living tissues and small animal models
27
CDAP step 2 (3 phases)
Clinical Trial Application and testing
Phase 1: healthy subjects (evaluate safety of drug and possible adverse effects)
-Phase 2: small group of patients with target condition
-Phase 2 large group of patients with target condition
28
CDAP step 3 (2)
manufacturer completes New Drug Submission (NDS) to Health Canada
-Outlines test data obtained from clinical trials, indication, adverse effects, production and packaging
29
CDAP step 4
committee of drug experts reviews NDS to identify benefits and risks
30
CDAP step 5
Health Canada shares information about drug with health care providers and consumers
31
CDAP step 6 (2)
if approved, Health Canada issues a Drug Information Number (DIN) and a Notice of Compliance to manufacturer
-Both required for marketing drug
32
CDAP step 7
Health Canada continues to evaluate drug safety and efficacy through quality assurance processes
33
safety after authorization
Health Canada monitors safety and effectiveness (how well it works) of drugs, devices and vaccines, called 'post-market surveillance'.
Study all 33 cards for free